VINC
Vincerx Pharma, Inc.
Key Financials
Operating Income
$-31463000
↑ 26.2%
Net Income
$-30074000
↑ 25.1%
EPS (Diluted)
$-15.85
0.0%
Total Assets
$8.0M
↓ 56.1%
Total Liabilities
$5.3M
↓ 24.5%
Shareholders' Equity
$2.7M
↓ 75.7%
Cash & Equivalents
$5.0M
↓ 61.0%
Operating Cash Flow
$-26127000.00
↑ 35.4%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13G/A | 7/29/2025 | View on SEC |
| DEFA14A | 7/16/2025 | View on SEC |
| DEFA14A | 7/7/2025 | View on SEC |
| 8-K | 7/7/2025 | View on SEC |
| DEFA14A | 6/18/2025 | View on SEC |
| DEFA14A | 6/6/2025 | View on SEC |
| 10-Q | 5/15/2025 | View on SEC |
| SCHEDULE 13G/A | 5/15/2025 | View on SEC |
| DEF 14A | 5/12/2025 | View on SEC |
| EFFECT | 5/2/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | VINC |
| Company Name | Vincerx Pharma, Inc. |
| CIK | 1796129 |
| Sector | Pharmaceutical Preparations |
| Industry | Emerging growth company |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| Phone | 650-800-6676 |